The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
CK2 in Cancer: Cellular and Biochemical Mechanisms and Potential Therapeutic Target
Open accessAbstract
CK2 genes are overexpressed in many human cancers, and most often overexpression is associated with worse prognosis. Site-specific expression in mice leads to cancer development (e.g., breast, lymphoma) indicating the oncogenic nature of CK2. CK2 is involved in many key aspects of cancer including inhibition of apoptosis, modulation of signaling pathways, DNA damage response, and cell cycle regulation. A number of CK2 inhibitors are now available and have been shown to have activity against various cancers in vitro and in pre-clinical models. Some of these inhibitors are now undergoing exploration in clinical trials as well. In this review, we will examine some of the major cancers in which CK2 inhibition has promise based on in vitro and pre-clinical studies, the proposed cellular and signaling mechanisms of anti-cancer activity by CK2 inhibitors, and the current or recent clinical trials using CK2 inhibitors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aloe-emodin-induced apoptosis in human gastric carcinoma cells
Chen, S.-H., Lin, K.-Y., Chang, C.-C., Fang, C.-L., & Lin, C.-P. (2007) · Food and Chemical Toxicology · doi:10.1016/j.fct.2007.06.005 · Cited by 112
Cited by
Protein kinase CK2: a potential therapeutic target for diverse human diseases
Borgo, C., D’Amore, C., Sarno, S., Salvi, M., & Ruzzene, M. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00567-7 · Cited by 362
Takeda, T., Komatsu, M., Chiwaki, F., Komatsuzaki, R., Nakamura, K., Tsuji, K., Kobayashi, Y., Tominaga, E., Ono, M., Banno, K., et al. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-2117-9 · Cited by 60
Basukala, O., Sarabia-Vega, V., & Banks, L. (2020) · Biological Chemistry · doi:10.1515/hsz-2019-0408 · Cited by 19
Metadata
- Authors
- Chua, M., Ortega, C., Sheikh, A., Lee, M., Abdul-Rassoul, H., Hartshorn, K., & Dominguez, I.
- Venue
- Pharmaceuticals
- Publisher
- MDPI AG
- Published
- 2017-01-28
- Volume
- 10
- Issue
- 1
- Pages
- 18
- ISSN
- 1424-8247 (ISSN-L)
- OpenAlex
- W2581414232
- Cited by
- 172
- References
- 1
- FWCI
- 12.61
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: CK2 in Cancer: Cellular and Biochemical Mechanisms and Potential Therapeutic Target. https://app.cochat.ai/papers/10.3390/ph10010018
- The paper
- Chua, M., Ortega, C., Sheikh, A., Lee, M., Abdul-Rassoul, H., Hartshorn, K., & Dominguez, I. (2017). CK2 in Cancer: Cellular and Biochemical Mechanisms and Potential Therapeutic Target. Pharmaceuticals. https://doi.org/10.3390/ph10010018
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.